Source Monophasic Hyaluronic Acid Filler for Wrinkles, Lips, and Face

Monophasic Hyaluronic Acid Filler Sourcing Guide

Monophasic hyaluronic acid fillers occupy a distinct position in the dermal filler category because the gel is manufactured as a single, uniform phase rather than being blended from particles of varying sizes. For procurement teams, this means the evaluation focus shifts toward cross-linking quality, gel homogeneity, and grade selection rather than comparing particulate blends. The products observed in this category are positioned as injectable hyaluronic acid fillers for wrinkle treatment, skin revitalization, firming, and anti-wrinkle use, supplied in cross-linked form.

This guide is written for distributors, clinic purchasing managers, and brand owners sourcing under OEM/ODM arrangements. Because injectable products carry elevated regulatory and safety obligations compared with topical skincare, the sections below set out what to verify before committing to a supplier: product scope, technical specifications, compliance documentation, commercial terms, supplier qualification, and the long-term checks that protect your supply continuity.

Product Scope and Observed Listing Signals

The observed listings cover a coherent product family: hyaluronic acid fillers offered in Fine, Derm, Deep, and Ultra-Deep grades, which map to the viscosity and gel firmness typically selected for different injection depths and treatment areas. Listed injection areas include forehead, face, eye, nose, lips, breast, buttocks, and body, so buyers should confirm which grades the supplier intends for which areas rather than assuming one grade serves all purposes. Ha concentration is listed at 24mg, and the material is described as 100% pure hyaluronic acid, also known as sodium hyaluronate.

Size options are notably broad: 1ml, 2ml, 3ml, 5ml, 10ml, 20ml, and 50ml are all observed, with some listings standardizing on 1ml syringes that include two needles, and others offering pre-filled packing. Packaging variants include box, carton, strong box, and aluminium foil bag, with express delivery mentioned. Customization is explicitly available, and supply type is listed as OEM/ODM, which matters if you plan private-label branding. Suitable users are listed as adults, both men and women, including elderly users, and usage mode is stated as external professional use.

Technical Specifications to Verify

Before ordering samples, request a written specification sheet for each grade you intend to stock. Key parameters to verify include the cross-linking technology, gel homogeneity, extrusion force, elasticity and cohesivity values, HA concentration confirmation (the observed listing states 24mg), residual cross-linker content, and particle-free monophasic structure. Ask how each grade—Fine, Derm, Deep, Ultra-Deep—differs in measured parameters, not just in marketing labels, so your clinical customers can match grade to indication with confidence.

Also verify the presentation details that affect usability and shelf performance: syringe volume per unit (observed standards include 1ml, 2ml, 3ml, 5ml, 10ml, 20ml, and 50ml), needle gauge and count, sterility method, and shelf life. One observed listing states a two-year self-life at room temperature storage, which is a meaningful logistics advantage if accurate, but you should confirm the storage claim against stability data rather than relying on the listing text alone.

Compliance and Safety Documentation

Certification claims in the observed listings include CE and CE ISO references, but a certificate mention on a product page is not the same as a verifiable credential. Request the actual certificate copies, confirm the issuing body, check the certificate scope covers injectable hyaluronic acid filler products specifically, and verify validity dates. If you sell into markets with their own medical device registration regimes—such as national regulatory approvals beyond CE—confirm early whether the supplier's documentation will support your registration pathway, because injectable fillers are typically classified as medical devices in most jurisdictions.

Safety documentation should include sterility validation, biocompatibility testing, endotoxin limits, and a certificate of analysis for each batch. Confirm the disinfection and sterilization process described in the listings is documented in a quality file you can review. Since these are injection-area products spanning face and body applications, ask whether the manufacturer holds production licensing for injectable medical devices in its country of origin—observed origins include China and Korea—and whether batch traceability records are maintained from raw material to finished syringe.

Cost Drivers and Commercial Terms

Observed prices in the category range from roughly USD 11 to USD 75, and observed MOQs span from 1 to 100 units, which signals wide variation in product format, grade, and order structure. Price drivers you should expect to negotiate around include HA concentration, grade depth (Ultra-Deep typically commands a premium over Fine Line), syringe volume, needle inclusion, packaging type (a strong box or aluminium foil bag adds cost versus a basic carton), and whether the order is standard-label or OEM/ODM customized. Express delivery versus consolidated freight also shifts landed cost.

Clarify the commercial terms in writing before the first paid order: unit price per grade and volume, MOQ per SKU, payment terms, what happens on price changes, and whether customization (branding, box design, needle configuration) carries tooling or setup fees. Because observed MOQs go as low as 1 unit, smaller buyers can run trial orders, but confirm whether trial pricing differs from repeat-order pricing so your margin model remains stable as volumes scale.

Supplier Qualification and Quality Control

Qualify suppliers through a structured process rather than page impressions. Start with document review: business license, medical device manufacturing license where applicable, CE and ISO certificates, and factory audit reports. Then move to sample evaluation: order samples across multiple grades (Fine through Ultra-Deep) and volumes, and have a qualified clinical professional assess handling, extrusion force, and gel consistency. One observed product family uses model identifiers such as OC206, NM-1, Filler-6, and Petit/Classic/Grand naming—confirm exactly which model and grade each quote refers to, since listings mix model codes freely.

Quality control should continue after qualification. Require certificates of analysis with each shipment, agree on incoming inspection criteria at your side, and establish a process for retention samples and complaint handling. Ask about in-process controls during manufacturing: cleanroom classification, sterile filling controls, and batch release procedures. For OEM/ODM arrangements, define in a written agreement who owns the specification, how changes to formulation or packaging are communicated, and what notice period applies before any change takes effect.

Long-Term Procurement Checks

Sustained supply of injectable fillers depends on continuity that only reveals itself over time. Build periodic re-verification into your contract: annual certificate refresh checks, requalification samples at defined intervals, and stability or shelf-life confirmations if the supplier updates packaging or sterilization methods. Track batch consistency by comparing certificates of analysis across shipments for the same grade—drift in measured parameters is an early signal of process changes that may not have been disclosed. Confirm storage requirements in writing, since the observed two-year room-temperature shelf life claim needs to remain valid through your distribution chain.

Diversification is the second pillar. Even after qualifying a primary supplier, maintain an approved secondary source for your core grades so a single factory disruption does not halt your sales. Keep a documented comparison of lead times, defect or complaint rates, and responsiveness across suppliers as you scale. Finally, monitor regulatory developments in your destination markets: classification changes, new labeling requirements, or updated certification expectations can affect which products you may continue importing, and early awareness protects both your inventory investment and your customers.